H. Lundbeck A/S
🇩🇰Denmark
- Country
- 🇩🇰Denmark
- Ownership
- Public, Subsidiary
- Established
- 2000-01-01
- Employees
- 5.6K
- Market Cap
- -
- Website
- http://www.lundbeck.com
Exploratory Study of the Effects of Vortioxetine (Lu AA21004) on Cognition and Blood Oxygen Level Dependent (BOLD) Functional Magnetic Resonance Imaging (fMRI) Signals in Subjects Remitted From Depression and in Controls
- First Posted Date
- 2012-05-28
- Last Posted Date
- 2013-09-25
- Lead Sponsor
- H. Lundbeck A/S
- Target Recruit Count
- 96
- Registration Number
- NCT01607125
- Locations
- 🇬🇧
GB001, Headington, United Kingdom
Study of Vortioxetine (Lu AA21004) in Major Depressive Disorder in Asian Countries
Phase 3
Completed
- Conditions
- Interventions
- First Posted Date
- 2012-04-05
- Last Posted Date
- 2014-10-13
- Lead Sponsor
- H. Lundbeck A/S
- Target Recruit Count
- 437
- Registration Number
- NCT01571453
Rasagiline in Early Parkinson's Disease Patients Not Treated With Levodopa in China
- First Posted Date
- 2012-03-16
- Last Posted Date
- 2014-12-23
- Lead Sponsor
- H. Lundbeck A/S
- Target Recruit Count
- 130
- Registration Number
- NCT01556165
- Locations
- 🇨🇳
CN005, Guangzhou, China
🇨🇳CN011, Chengdu, China
🇨🇳CN004, Hangzhou, China
Pharmacokinetics and Tolerability of Vortioxetine (Lu AA21004) in Child and Adolescent Patients With Depressive or Anxiety Disorder
- First Posted Date
- 2011-12-13
- Last Posted Date
- 2017-03-16
- Lead Sponsor
- H. Lundbeck A/S
- Target Recruit Count
- 48
- Registration Number
- NCT01491035
- Locations
- 🇺🇸
US004, Wichita, Kansas, United States
🇺🇸US002, Cincinnatti, Ohio, United States
🇺🇸US003, Washington, District of Columbia, United States
A Study of Vortioxetine (Lu AA21004) in Comparison to Agomelatine in Adults Suffering From Major Depression With Inadequate Response to Previous Medication
Phase 3
Completed
- Conditions
- Interventions
- First Posted Date
- 2011-12-08
- Last Posted Date
- 2014-03-26
- Lead Sponsor
- H. Lundbeck A/S
- Target Recruit Count
- 495
- Registration Number
- NCT01488071
Azilect® (Rasagiline) in Levodopa-treated Parkinson's Patients With Motor Fluctuations in China
- First Posted Date
- 2011-11-24
- Last Posted Date
- 2018-09-10
- Lead Sponsor
- H. Lundbeck A/S
- Target Recruit Count
- 321
- Registration Number
- NCT01479530
- Locations
- 🇨🇳
CN017, Beijing, China
🇨🇳CN015, Beijing, China
🇨🇳CN008, Beijing, China
A Prospective Epidemiological Research on Functioning Outcomes Related to Major Depressive Disorder
Completed
- Conditions
- First Posted Date
- 2011-09-01
- Last Posted Date
- 2015-07-08
- Lead Sponsor
- H. Lundbeck A/S
- Target Recruit Count
- 1455
- Registration Number
- NCT01427439
- Locations
- 🇫🇷
FR, Paris, France
Efficacy Study of Vortioxetine on Cognitive Dysfunction in Adult Patients With Major Depressive Disorder
Phase 3
Completed
- Conditions
- Interventions
- First Posted Date
- 2011-08-23
- Last Posted Date
- 2014-08-05
- Lead Sponsor
- H. Lundbeck A/S
- Target Recruit Count
- 598
- Registration Number
- NCT01422213
Bioequivalence Study Comparing Two Formulations of Escitalopram
- First Posted Date
- 2011-07-15
- Last Posted Date
- 2012-12-10
- Lead Sponsor
- H. Lundbeck A/S
- Target Recruit Count
- 32
- Registration Number
- NCT01395433
- Locations
- 🇳🇱
NL001, Leiden, Netherlands
Study of the Safety, Tolerability, and Pharmacokinetics of Once Weekly Zicronapine in Patients With Schizophrenia
- First Posted Date
- 2011-06-21
- Last Posted Date
- 2016-03-22
- Lead Sponsor
- H. Lundbeck A/S
- Target Recruit Count
- 46
- Registration Number
- NCT01377233
- Locations
- 🇺🇸
US001, Rockville, Maryland, United States
🇺🇸US004, San Diego, California, United States
🇺🇸US003, National City, California, United States
© Copyright 2024. All Rights Reserved by MedPath